Prelude Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-53
| Closed | -$5K | – | 1992 |
|
|
2020
Q2 | $5K | Buy |
+53
| New | +$5K | ﹤0.01% | 1172 |
|
|
2019
Q1 | – | Sell |
-6
| Closed | -$12K | – | 1855 |
|
|
2018
Q4 | $12K | Buy |
6
+1
| +20% | +$2K | ﹤0.01% | 1009 |
|
|
2018
Q3 | $11K | Buy |
+5
| New | +$11K | ﹤0.01% | 1087 |
|
|
2018
Q2 | – | Sell |
-15
| Closed | -$43K | – | 1747 |
|
|
2018
Q1 | $43K | Sell |
15
-13
| -46% | -$37.3K | ﹤0.01% | 993 |
|
|
2017
Q4 | $73K | Sell |
28
-1
| -3% | -$2.61K | 0.01% | 766 |
|
|
2017
Q3 | $83K | Sell |
29
-55
| -65% | -$157K | 0.01% | 862 |
|
|
2017
Q2 | $199K | Sell |
84
-3
| -3% | -$7.11K | 0.02% | 519 |
|
|
2017
Q1 | $219K | Sell |
87
-64
| -42% | -$161K | 0.02% | 493 |
|
|
2016
Q4 | $341K | Buy |
+151
| New | +$341K | 0.04% | 368 |
|
|
2016
Q3 | – | Sell |
-93
| Closed | -$286K | – | 1814 |
|
|
2016
Q2 | $286K | Buy |
93
+77
| +481% | +$237K | 0.04% | 366 |
|
|
2016
Q1 | $50K | Buy |
+16
| New | +$50K | 0.01% | 903 |
|
|
2015
Q3 | – | Sell |
-17
| Closed | -$67K | – | 1791 |
|
|
2015
Q2 | $67K | Buy |
17
+5
| +42% | +$19.7K | 0.01% | 972 |
|
|
2015
Q1 | $47K | Sell |
12
-28
| -70% | -$110K | 0.01% | 1263 |
|
|
2014
Q4 | $196K | Hold |
40
| – | – | 0.03% | 609 |
|
|
2014
Q3 | $163K | Buy |
40
+8
| +25% | +$32.6K | 0.02% | 731 |
|
|
2014
Q2 | $128K | Buy |
32
+12
| +60% | +$48K | 0.02% | 882 |
|
|
2014
Q1 | $91K | Sell |
20
-24
| -55% | -$109K | 0.01% | 920 |
|
|
2013
Q4 | $153K | Hold |
44
| – | – | 0.03% | 627 |
|
|
2013
Q3 | $182K | Sell |
44
-66
| -60% | -$273K | 0.03% | 498 |
|
|
2013
Q2 | $434K | Buy |
+110
| New | +$434K | 0.09% | 244 |
|